Gene · 6520
Papers4,329
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 4,329
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Global, site-resolved analysis of ubiquitylation occupancy and turnover rate reveals systems properties. | Cell | 2024 | 38626770 | PubTator, text mining | PubMed |
| Mechanism and functional verification of genes by virulence factors of P. gingivalis in ferroptosis. | Arch Oral Biol | 2024 | 38593562 | PubTator, text mining | PubMed |
| Cryo-EM structure of the human Asc-1 transporter complex. | Nat Commun | 2024 | 38589439 | PubTator, text mining | PubMed |
| Structure and mechanisms of transport of human Asc1/CD98hc amino acid transporter. | Nat Commun | 2024 | 38582862 | PubTator, text mining | PubMed |
| Integrated in vivo functional screens and multi-omics analyses identify α-2,3-sialylation as essential for melanoma maintenance. | bioRxiv | 2024 | 38559078 | PubTator, text mining | PubMed |
| Microbiome Dysbiosis Is Associated with Castration Resistance and Cancer Stemness in Metastatic Prostate Cancer. | Int J Mol Sci | 2024 | 38542265 | PubTator, text mining | PubMed |
| Association of the rs1966265 and rs351855 FGFR4 Variants with Colorectal Cancer in a Mexican Population and Their Analysis In Silico. | Biomedicines | 2024 | 38540215 | PubTator, text mining | PubMed |
| Integrated analysis of disulfidptosis-related immune genes signature to boost the efficacy of prognostic prediction in gastric cancer. | Cancer Cell Int | 2024 | 38528532 | PubTator, text mining | PubMed |
| Rab4A-directed endosome traffic shapes pro-inflammatory mitochondrial metabolism in T cells via mitophagy, CD98 expression, and kynurenine-sensitive mTOR activation. | Nat Commun | 2024 | 38519468 | PubTator, text mining | PubMed |
| Asymmetric T-cell division: insights from cutting-edge experimental techniques and implications for immunotherapy. | Front Immunol | 2024 | 38495874 | PubTator, text mining | PubMed |
| Ex vivo activation of the GCN2 pathway metabolically reprograms T cells, leading to enhanced adoptive cell therapy. | Cell Rep Med | 2024 | 38460518 | PubTator, text mining | PubMed |
| Dynein functions in galectin-3 mediated processes of clathrin-independent endocytosis. | J Biosci | 2024 | 38445557 | PubTator, text mining | PubMed |
| Functional and Immunologic Mapping of Domains of the Reticulocyte-Binding Protein Plasmodium vivax PvRBP2a. | J Infect Dis | 2024 | 38441336 | PubTator, text mining | PubMed |
| Identification and validation of RNA-binding protein SLC3A2 regulates melanocyte ferroptosis in vitiligo by integrated analysis of single-cell and bulk RNA-sequencing. | BMC Genomics | 2024 | 38438962 | PubTator, text mining | PubMed |
| Expert Consensus on the Diagnosis and Treatment of NRG1/2 Gene Fusion Solid Tumors. | Glob Med Genet | 2024 | 38414979 | PubTator, text mining | PubMed |
| Metabolic Responses of Lung Adenocarcinoma Cells to Survive under Stressful Conditions Associated with Tumor Microenvironment. | Metabolites | 2024 | 38392995 | PubTator, text mining | PubMed |
| Acidosis activates breast cancer ferroptosis through ZFAND5/SLC3A2 signaling axis and elicits M1 macrophage polarization. | Cancer Lett | 2024 | 38360142 | PubTator, text mining | PubMed |
| Tumor volume and cancer stem cell expression as prognostic markers for high-dose loco-regional failure in head and neck squamous cell carcinoma - A DAHANCA 19 study. | Radiother Oncol | 2024 | 38341096 | PubTator, text mining | PubMed |
| Effect of disulfidptosis-related genes SLC3A2, SLC7A11 and FLNB polymorphisms on risk of autoimmune thyroiditis in a Chinese population. | Int Immunopharmacol | 2024 | 38316082 | PubTator, text mining | PubMed |
| Metabolic alterations of peripheral blood immune cells and heterogeneity of neutrophil in intracranial aneurysms patients. | Clin Transl Med | 2024 | 38314932 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6520/papers?page=16